Nonprofit healthcare centers are lobbying for a special exemption from a new Health and Human Services reimbursement review ...

Drugmaker Eli Lilly and Co. is restricting access to a drug discount program intended for safety-net hospitals in a move the ...

AHA president has asked Congress to intervene and demand HHS take a position on “drug companies’ attempts to hijack the 340B ...

The draft from Sen. Bill Cassidy on reforms to the 340B program requires hospitals to divulge how many people received drugs ...

A federal judge on Monday temporarily blocked the U.S. administration’s planned 340B Rebate Model Pilot Program, finding that regulators likely failed to meet basic administrative law requirements ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last ...

Though it used the majority of its public comment letter making the case against drug manufacturer-preferred rebates for 340B drugs, the American Hospital Association also outlined "bare minimum ...

After years of investigation, the outgoing chairman of the Senate Health, Education, Labor and Pensions Committee has ...

Policies written with the best intentions can be misinterpreted or misused. This is especially true if proper oversight is lacking or if new policy creates unforeseen opportunities. I believe this is ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...